Morbidity and Quality of Life in Bladder Cancer Patients following Cystectomy and Urinary Diversion: A Single-Institution Comparison of Ileal Conduit versus Orthotopic Neobladder
Table 3
QLQ-C30.
QLQ-C30
Ileal conduit Mean ± standard dev. Median (interquartile range) of cases
Ileal neobladder Mean ± standard dev. Median (interquartile range) of cases
Functional scales
Global health status/quality of lifea
58.3 (33.3–83.3)
70.8 (56.2–85.4)
Physical functioningb
70 (33.3–93.3)
93.3 (71.6–100)
Role functioning
66.7 (33.3–100)
83.3 (50–100)
Emotion functioning
70.8 (52.1–91.7)
87.5 (66.7–100)
Cognitive functioning
83.3 (54.2–100)
83.3 (66.7–100)
Social functioning
83.3 (33.3–95.8)
75 (45.8–100)
Symptoms scales
Fatigue
33.3 (11.1–63.9)
16.7 (0–55.6)
Nausea and vomiting
0 (0–12.5)
0 (0-0)
Pain
8.3 (0–50)
0 (0–33.3)
Single items
Dyspnoea
33 (0–66.7)
0 (0–41.7)
Insomnia
33.3 (0–66.7)
0 (0–33.3)
Appetite loss
0 (0–33.3)
0 (0-0)
Constipation
0 (0–33.3)
0 (0–33.3)
Diarrhoeac
0 (0-0)
0 (0–33.3)
Financial difficulties
0 (0–66.7)
0 (0–41.7)
at-test; .
bU test; .
cU test; . EORTC QLQ-C30 results of this study. The questionnaire assesses cancer-specific QOL. For all the questions, a scale from 1 to 4 was used (1: not at all, 2: a little, 3: quite a bit, 4: very much). All scores were linearly transformed such that all scales range from 0 to 100. For the six functional items, the higher score represents a higher level of functioning and for the symptoms/single items, a higher score means a higher level of symptomatology/problems.